ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Komen Foundation Calls For Review Of Action Plan’s Goals

October 24, 1996

Breast-Conserving Procedures Lead To Frequent Follow-up Care

April 27, 2012

Amgen Commits $1.5M To CDC Foundation For Education Program

May 29, 2009

In Brief: Hawaii Center Searching For New Director: Rosenberg Denies Report He’s Going To Tampa

June 7, 1985

IPRI’s Peter Boyle on Closing the Gap In Global Cancer Treatment And Outcomes

January 31, 2014

DRG Executives Names By DeVita as Director Of DEA; Other Sections Reportedly Made, Not Yet Approved

July 31, 1981